-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LzyjT40uOHiUBBbiaTE7gJZ2eMzpwVa2PsL6WpNJQmp5phA+HNoGwBwWyovuN+TO Bud7nJfDDTRycxtOYQ7IuA== 0001179110-06-010010.txt : 20060504 0001179110-06-010010.hdr.sgml : 20060504 20060504174554 ACCESSION NUMBER: 0001179110-06-010010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060502 FILED AS OF DATE: 20060504 DATE AS OF CHANGE: 20060504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JAKUBOWSKI AUDREY F CENTRAL INDEX KEY: 0001263622 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27628 FILM NUMBER: 06809674 MAIL ADDRESS: STREET 1: C/O SUPERGEN, INC. STREET 2: 4140 DUBLIN BLVD., SUITE 200 CITY: DUBLIN STATE: CA ZIP: 94568 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERGEN INC CENTRAL INDEX KEY: 0000919722 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911841574 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4140 DUBLIN BLVD STREET 2: SUITE 200 CITY: DUBLIN STATE: CA ZIP: 94568 BUSINESS PHONE: 9255600100 MAIL ADDRESS: STREET 1: 4140 DUBLIN BLVD STREET 2: STE 200 CITY: DUBLIN STATE: CA ZIP: 94568 4 1 edgar.xml FORM 4 - X0202 4 2006-05-02 0 0000919722 SUPERGEN INC SUPG 0001263622 JAKUBOWSKI AUDREY F C/O SUPERGEN, INC. 4140 DUBLIN BLVD, SUITE 200 DUBLIN CA 94568 0 1 0 0 Chief Reg & Compliance Officer Employee Stock Option (Right to buy) 5.38 2006-05-02 4 A 0 15200 0 A 2016-05-02 Common Stock 15200 15200 D Employee Stock Option (Right to buy) 5.74 2006-05-03 4 A 0 10000 0 A 2006-05-03 2016-03-24 Common Stock 10000 10000 D Employee Stock Option 5.22 2006-05-03 4 A 0 6000 0 A 2006-05-03 2016-05-03 Common Stock 6000 6000 D Grant to reporting person of option to buy 15,200 shares of Common Stock under the Issuer's 2003 Stock Plan. The option vests and becomes exercisable as to 1/19th of the shares on June 1, 2006 and at the end of each full month thereafter. On March 24, 2006, reporting person was granted an option to buy 10,000 shares of Common Stock under the Issuer's 2003 Stock Plan. The option became fully vested upon FDA approval of Dacogen, which approval was received on May 3, 2006. /s/ Audrey F. Jakubowski 2006-05-04 -----END PRIVACY-ENHANCED MESSAGE-----